ProSystem CE

Clostridium Perfringens Type C-Escherichia Coli Bacterin-Toxoid

This product has been shown to be effective for the vaccination of healthy pregnant swine to provide passive immunity against colibacillosis and enterotoxemia due to Escherichia coli antigens (K88, K99, F41 and 987P) and Clostridium perfringens Type C toxin in piglets. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

This product has also been shown to be effective against clinical diseases and mortality due to E. coli 987P in nursing piglets.

DOSAGE AND DIRECTIONS: Gently agitate vial and aseptically administer 2 mL dose intramuscularly or subcutaneously to healthy pregnant swine, during the latter part of pregnancy at 5 weeks and again at 2 weeks before farrowing. In subsequent farrowings, administer 2 mL dose 2-3 weeks before farrowing.

ProSystem CE Caution

Store at 2 to 8°C (35 to 46°F). Fetal health risks associated with the vaccination of pregnant animals with this vaccine cannot be unequivocally determined during clinical trials conducted for licensure. Appropriate strategies to address the risks associated with vaccine use in pregnant animals should be discussed with a veterinarian. Use entire contents when first opened. Do not mix with other products. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use. Antidote: Epinephrine. Contains Thimerosal and polymyxin B as preservatives. In case of human exposure, contact a physician.

FOR ANIMAL USE ONLY

Intervet Inc., d/b/a Merck Animal Health, Omaha, Nebraska 68103 USA

VLN 165A/PCN 7890.01

1 800 521-5767

For patent information:

http://www.merck.com/product/patent/home.html

CPN: 1047370.4